Abstract Background Sarcopenia, characterised by a loss of muscle strength, quantity/quality, and physical performance, is associated with increased mortality poor clinical outcomes in patients liver cirrhosis. The use the currently accepted methods for estimating mass, such as computed tomography, dual-energy X-ray absorptiometry, bioelectrical impedance analysis, routine practice restricted b...